文献速递神经肿瘤

胶质母细胞瘤治疗面临的挑战:多系统治疗耐药机制

Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance.
PubMed 文献 · World Neurosurg · 2018-01-01

本文综述胶质母细胞瘤治疗耐药的多系统机制,包括血脑屏障限制药物入脑、肿瘤异质性、干细胞样特性及代谢重编程等,并讨论精准医学时代分子技术靶向个体化肿瘤以规避耐药的希望。

要点

  • 血脑屏障和正常脑组织作用限制药物进入中枢神经系统。
  • 胶质母细胞瘤异质性使单药难以控制整个肿瘤并促进靶向药物逃逸。
  • 干细胞样特性通过外排转运体上调、神经发生区增殖和免疫抑制分别促进化疗、放疗和免疫治疗耐药。

核心结论

  • 每种耐药机制都对胶质母细胞瘤的有效治疗提出一系列挑战,随着领域认识和解决这些困难,未来治疗可能对患者更有效和更有希望。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • 血脑屏障限制药物进入中枢神经系统,正常脑组织作用对抗肿瘤靶向药物。
  • 胶质母细胞瘤的巨大异质性通过阻止单药充分控制整个肿瘤和促进靶向药物逃逸导致显著治疗耐药。
  • 干细胞样特性通过外排转运体上调、促进胶质母细胞瘤干细胞在神经发生区增殖和免疫抑制分别促进化疗、放疗和免疫治疗耐药。
  • 代谢级联通过优化葡萄糖利用、使用替代营养前体供能和诱导缺氧增强肿瘤生长,从而妨碍有效治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glioblastoma is one of the most lethal human cancers, with poor survival despite surgery, radiation treatment, and chemotherapy. Advances in the treatment of this type of brain tumor are limited because of several resistance mechanisms. Such mechanisms involve limited drug entry into the central nervous system compartment by the blood-brain barrier and by actions of the normal brain to counteract tumor-targeting medications. In addition, the vast heterogeneity in glioblastoma contributes to significant therapeutic resistance by preventing adequate control of the entire tumor mass by a single drug and by facilitating escape mechanisms from targeted agents. The stem cell-like characteristics of glioblastoma promote resistance to chemotherapy, radiation, and immunotherapy through upregulation of efflux transporters, promotion of glioblastoma stem cell proliferation in neurogenic zones, and immune suppression, respectively. Metabolic cascades in glioblastoma prevent effective treatments through the optimization of glucose use, the use of alternative nutrient precursors for energy production, and the induction of hypoxia to enhance tumor growth. In the era of precision medicine, an assortment of molecular techniques is being developed to target an individual's unique tumor, with the hope that this personalized strategy will bypass therapeutic resistance. Although each resistance mechanism presents an array of challenges to effective treatment of glioblastoma, as the field recognizes and addresses these difficulties, future treatments may have more efficacy and promise for patients with glioblastoma.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Noch EK, Ramakrishna R, Magge R, et al. Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance. World Neurosurg. 2018. PMID: 30049045. doi:10.1016/j.wneu.2018.04.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。